Skip to main content
. 2022 Jan 8;14(2):308. doi: 10.3390/cancers14020308

Table 2.

Bias-adjusted hazard ratios and optimal cutpoints for dichotomized metrics.

Metric Dichotomization
Threshold (#)
Hazard
Ratio (*)
LL 95%CI UL 95%CI p (&)
High vs. low number of CD163+ TAMs 70 (12–102) 2.97 1.73 5.11 <0.001
High vs. low proportion of CD163+ TAMs 0.038 (0.004–0.149) 1.94 1.20 3.14 0.026
High vs. low 10th PCTL of cancer-to-CD163+ NNDs 13 (7–55) 0.60 0.38 0.94 0.027
High vs. low 25th PCTL of cancer-to-CD163+ NNDs 17 (9–42) 0.46 0.26 0.82 0.026
High vs. low median cancer-to-CD163+ NND 19 (13–74) 0.48 0.27 0.85 0.026
High vs. low average number of adjacent CD163+ TAMs 0.034 (0.022–0.087) 2.71 1.70 4.32 <0.001
High vs. low average number of communicating CD163+ TAMs 46 (21–57) 2.96 1.80 4.87 <0.001

(#) bootstrap-based 90% confidence interval in parentheses. (&) adjusted for multiple testing using Holm’s method. (*) bootstrap-based optimistic bias-adjusted hazard ratio.